Brief: Structure Therapeutics Inc - Gasherbrum Entered Agreement With Genentech And Roche - SEC Filing
05/01/2026 22:15
Structure Therapeutics Inc GPCR.O: STRUCTURE THERAPEUTICS INC - GASHERBRUM ENTERED AGREEMENT WITH GENENTECH AND ROCHE - SEC FILING STRUCTURE THERAPEUTICS INC - GENENTECH TO PAY GASHERBRUM $100 MILLION - SEC FILING Source text: [ID:n0001104659-26-000620] Further company coverage: GPCR.O
Recent news on Structure Therapeutics
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Structure falls as investors await more obesity trial data, says Jefferies